Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3
Open Access
- 13 June 2022
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (6) , 1-11
Abstract
Epigenetic dysregulation contributes to bladder cancer tumorigenesis. H3K36me2 demethylase KDM2A functions as an important epigenetic regulator of cell fate in many types of tumors. However, its role in bladder cancer remains unknown. Here, we revealed a positive correlation between KDM2A gene copy number gain and upregulation of KDM2A mRNA expression in bladder cancer. Moreover, a super-enhancer (SE) driving KDM2A transcription was found in high-grade bladder cancer, resulting in a significantly higher expression of KDM2A mRNA compared to that in low-grade bladder tumors. KDM2A knockdown (KD) decreased the proliferation, invasion, and spheroid formation of high-grade bladder cancer cells and inhibited tumor growth in mouse xenograft models. Furthermore, we identified RARRES3 as a key KDM2A target gene. KDM2A suppresses RARRES3 expression via demethylation of H3K36me2 in the RARRES3 promoter. Intriguingly, RARRES3 KD attenuated the inhibitory effects of KDM2A depletion on the malignant phenotypes of high-grade bladder cancer cells. The combination of the KDM2A inhibitor IOX1 and the RARRES3 agonist all-trans retinoic acid (ATRA) synergistically inhibited the proliferation of high-grade bladder cancer cells, suggesting that the KDM2A/RARRES3 axis may be a promising therapeutic target for the treatment of high-grade bladder cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82002845, 81972651, 82172698, 81922046, 61931024)
- National Key Research and Development Program of Chin
This publication has 44 references indexed in Scilit:
- KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signalingJournal of Clinical Investigation, 2013
- Demethylation of Epiregulin Gene by Histone Demethylase FBXL11 and BCL6 Corepressor Inhibits Osteo/dentinogenic DifferentiationStem Cells, 2012
- Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastomaActa Neuropathologica, 2012
- Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARAOncogene, 2011
- Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joiningProceedings of the National Academy of Sciences, 2010
- Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment StrategyEuropean Urology, 2009
- The diverse functions of histone lysine methylationNature Reviews Molecular Cell Biology, 2005
- All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivoOncogene, 2005
- The key to development: interpreting the histone code?Current Opinion in Genetics & Development, 2005
- An epigenetic road map for histone lysine methylationJournal of Cell Science, 2003